{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:40:03Z","timestamp":1747309203129,"version":"3.40.5"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","award":["ICyT-PINV11-26","INP-2040","NIDA-1R01DA030715-01","SEP-CONACYT-2009-I0003-106549"],"award-info":[{"award-number":["ICyT-PINV11-26","INP-2040","NIDA-1R01DA030715-01","SEP-CONACYT-2009-I0003-106549"]}],"id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107887","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:05:00Z","timestamp":1624694700000},"page":"107887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The morphine\/heroin vaccine decreased the heroin-induced antinociceptive and reinforcing effects in three inbred strains mouse"],"prefix":"10.1016","volume":"98","author":[{"given":"Susana","family":"Barbosa-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Matus-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Hern\u00e1ndez-Miramontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Salazar-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107887_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","article-title":"The Opioid Epidemic: Crisis and Solutions","volume":"58","author":"Skolnick","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2021.107887_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.intimp.2021.107887_b0015","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","article-title":"Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics","volume":"122","author":"Kreek","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.107887_b0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11597520-000000000-00000","article-title":"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals","volume":"72","author":"Tetrault","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2021.107887_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.intimp.2021.107887_b0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate Vaccine Immunotherapy for Substance Use Disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2021.107887_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"doi-asserted-by":"crossref","unstructured":"A. Salazar-Ju\u00e1rez, S. Barbosa-M\u00e9ndez, M.I. Feregrino-Alonso, R. Hern\u00e1ndez-Miramontes, E. Ramos-Ochoa, E. Bonilla-Reyes, S. Jacinto-Gutierrez, P. Pente, B. Ant\u00f3n, Nuevas Vacunas contra la morfina\/hero\u00edna. Salud Mental 2013; 36: 219\u2013227.","key":"10.1016\/j.intimp.2021.107887_b0040","DOI":"10.17711\/SM.0185-3325.2013.028"},{"key":"10.1016\/j.intimp.2021.107887_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.intimp.2021.107887_b0050","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107887_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol Psychiatry"},{"key":"10.1016\/j.intimp.2021.107887_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.107887_b0065","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0070","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.intimp.2021.107887_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl potency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2021.107887_b0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1016\/j.intimp.2021.107887_b0085","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","volume":"18","author":"Li","year":"2014","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"10.1016\/j.intimp.2021.107887_b0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.107887_b0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0105","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/187152711799219316","article-title":"Developing a vaccine against multiple psychoactive targets: a case study of heroin","volume":"10","author":"Stowe","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.intimp.2021.107887_b0115","article-title":"Effect of the morphine\/heroin vaccine on opioid and non-opioid drug-induced antinociception in mice","author":"Barbosa-Mendez","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107887_b0120","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1021\/acs.molpharmaceut.8b00592","article-title":"Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins","volume":"15","author":"Baruffaldi","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0125","first-page":"1075","article-title":"Investigating the Effects of a Hydrolytically Stable Hapten and a Th1 Adjuvant on Heroin Vaccine Performance","volume":"11","author":"Bremer","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0135","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.intimp.2021.107887_b0140","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a Clinically Viable Heroin Vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.intimp.2021.107887_b0145","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acschemneuro.8b00079","article-title":"Efficacious Vaccine against Heroin Contaminated with Fentanyl","volume":"9","author":"Hwang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2021.107887_b0150","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1021\/acsomega.8b01478","article-title":"Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin","volume":"3","author":"Hwang","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.intimp.2021.107887_b0155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0160","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.vaccine.2019.05.061","article-title":"Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences","volume":"37","author":"Hwang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107887_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmc.2018.11.027","article-title":"Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin","volume":"27","author":"Hwang","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0170","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107887_b0175","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3762\/bjoc.15.100","article-title":"A chemically contiguous hapten approach for a heroin-fentanyl vaccine","volume":"15","author":"Natori","year":"2019","journal-title":"Beilstein J. Org. Chem."},{"doi-asserted-by":"crossref","unstructured":"M. Pravetoni, M.D. Raleigh, M. Le Naour. Tucker AM. Harmon TM. Jones JM. Birnbaum AK. Portoghese PS. Pentel PR. Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine 2012; 30: 4617\u20134624.","key":"10.1016\/j.intimp.2021.107887_b0180","DOI":"10.1016\/j.vaccine.2012.04.101"},{"key":"10.1016\/j.intimp.2021.107887_b0185","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1039\/C4OB01053A","article-title":"Synthesis and immunological effects of heroin vaccines","volume":"12","author":"Li","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as an effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.intimp.2021.107887_b0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41386-019-0385-9","article-title":"Conjugate vaccine produces long-lasting attenuation of fentanyl vs.food choice and blocks expression of opioid withdrawal-induced increases infentanyl choice in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2021.107887_b0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1534\/genetics.114.165449","article-title":"The genetics of immunity","volume":"197","author":"Lazzaro","year":"2014","journal-title":"Genetics"},{"key":"10.1016\/j.intimp.2021.107887_b0205","first-page":"4","article-title":"Genetic control of the innate immune response","volume":"26","author":"Wells","year":"2003","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2021.107887_b0210","doi-asserted-by":"crossref","first-page":"14811","DOI":"10.1038\/ncomms14811","article-title":"The comparative immunology of wild and laboratory mice","volume":"8","author":"Abolins","year":"2017","journal-title":"Mus. musculus domesticus. Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107887_b0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000509716","article-title":"Different Innate Immune Responses in BALB\/c and C57BL\/6 Strains following Corneal Transplantation","volume":"13","author":"Bleul","year":"2021","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.intimp.2021.107887_b0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.intimp.2021.107887_b0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12975-016-0455-9","article-title":"Strain-Related Differences in the Immune Response: Relevance to Human Stroke","volume":"7","author":"Becker","year":"2016","journal-title":"Transl Stroke Res."},{"key":"10.1016\/j.intimp.2021.107887_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/iai.19.1.123-130.1978","article-title":"Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents","volume":"19","author":"Parker","year":"1978","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2021.107887_b0235","first-page":"433","article-title":"Differences in innate immune response between man and mouse","volume":"34","author":"Zschaler","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107887_b0240","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41592-018-0224-7","article-title":"Comparing phenotypic variation between inbred and outbred mice","volume":"15","author":"Tuttle","year":"2018","journal-title":"Nat. Methods"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2021.107887_b0245","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/infdis\/jit448","article-title":"Humoral immunity in humanized mice: a work in progress","volume":"208","author":"Seung","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107887_b0250","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cei.12841","article-title":"The genetic background influences the cellular and humoral immune responses to vaccines","volume":"186","author":"Zeng","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2021.107887_b0255","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2015.08.011","article-title":"BALB\/c and C57BL\/6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity","volume":"43","author":"Fransen","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.107887_b0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.exer.2005.06.010","article-title":"Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb\/c and C57BL\/6 mice","volume":"82","author":"Fukushima","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2021.107887_b0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FBP.0b013e328343d7dd","article-title":"Age-dependent and strain-dependent influences of morphine on mouse social investigation behavior","volume":"22","author":"Kennedy","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107887_b0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2009.12.021","article-title":"Genetic variance contributes to dopamine and opioid receptor antagonist-induced inhibition of intralipid (fat) intake in inbred and outbred mouse strains","volume":"1316","author":"Dym","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2021.107887_b0275","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1590\/S0100-879X2011007500142","article-title":"Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology","volume":"45","author":"Lemaire","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.intimp.2021.107887_b0280","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1590\/S0074-02762002000700019","article-title":"Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease","volume":"97","author":"Amaral","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.intimp.2021.107887_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046043","article-title":"Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice","volume":"7","author":"Mao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.107887_b0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2016.02.010","article-title":"Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats","volume":"68","author":"Salazar-Ju\u00e1rez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2021.107887_b0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2017.12.033","article-title":"Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats","volume":"820","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107887_b0300","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.120.000124","article-title":"Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats","volume":"375","author":"Baehr","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2018.02.006","article-title":"Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex","volume":"275","author":"Beck","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.intimp.2021.107887_b0310","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine, correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers","volume":"26","author":"Jalah","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0315","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107887_b0320","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acs.jmedchem.7b01427","article-title":"A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse","volume":"61","author":"Sulima","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107887_b0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-017-0013-9","article-title":"Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant","volume":"2","author":"Torres","year":"2017","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.intimp.2021.107887_b0330","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41598-018-23777-6","article-title":"Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose","volume":"8","author":"Laudenbach","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2021.107887_b0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.micpath.2018.12.045","article-title":"Evaluation of the protective effect of immunization spf DBA\/2J mice with selected bacterial, recombinant Hsp60 antigens during Salmonella Enteritidis challenge","volume":"128","author":"Bajzert","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2021.107887_b0340","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12275-013-3428-7","article-title":"DBA\/2 mouse as an animal model for anti-influenza drug efficacy evaluation","volume":"51","author":"Kim","year":"2013","journal-title":"J. Microbiol."},{"key":"10.1016\/j.intimp.2021.107887_b0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10517-017-3740-z","article-title":"Local and Systemic Functional Responses of Mouse Macrophages to Intravaginal Infection with Type 2 Herpes Simplex Virus and Vaccination","volume":"163","author":"Zaitseva","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2021.107887_b0350","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.02444-09","article-title":"Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA\/2 mouse influenza model","volume":"84","author":"Boon","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.intimp.2021.107887_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.602453","article-title":"Susceptibility Analysis in Several Mouse Strains Reveals Robust T-Cell Responses After Mycoplasma pneumoniae Infection in DBA\/2 Mice","volume":"10","author":"Tamiya","year":"2021","journal-title":"Front Cell Infect. Microbiol."},{"key":"10.1016\/j.intimp.2021.107887_b0360","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.xphs.2016.02.031","article-title":"Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges","volume":"105","author":"Jiskoot","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2021.107887_b0365","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The Role of Opioid Receptors in Immune System Function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2021.107887_b0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1360-0443.1993.tb00809.x","article-title":"The effects of methadone on immune function among injecting drug users: a review","volume":"88","author":"McLachlan","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.intimp.2021.107887_b0375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4684-5925-8_21","article-title":"Opiates as immunosuppressive and genotoxic agents","volume":"288","author":"Falek","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2021.107887_b0380","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0385","first-page":"754","article-title":"Characterization of the mu and delta-opioid receptors in the brain of the C57BL\/6 and DBA\/2 mice, selected for their differences in voluntary ethanol consumption","volume":"21","author":"de Waele","year":"1997","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.intimp.2021.107887_b0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.alcalc.a008216","article-title":"Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies","volume":"31","author":"Gianoulakis","year":"1996","journal-title":"Alcohol. Suppl."},{"key":"10.1016\/j.intimp.2021.107887_b0395","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0024-3205(97)00864-3","article-title":"The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL\/6J and DBA\/2J mice","volume":"61","author":"Petruzzi","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2021.107887_b0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(85)90239-0","article-title":"Species differences in the concentrations and distributions of opioid binding sites","volume":"112","author":"Robson","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107887_b0405","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1530-0277.1991.tb00576.x","article-title":"Endogenous opioids are involved in the genetically determined high preference for ethanol consumption","volume":"15","author":"George","year":"1991","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.intimp.2021.107887_b0410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0594-54","article-title":"Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains","volume":"7","author":"Berrettini","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2021.107887_b0415","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1038\/npp.2008.14","article-title":"Fine mapping of a major QTL influencing morphine preference in C57BL\/6 and DBA\/2 mice using congenic strains","volume":"33","author":"Doyle","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.intimp.2021.107887_b0420","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.npp.1300592","article-title":"Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains","volume":"30","author":"Ferraro","year":"2005","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.intimp.2021.107887_b0425","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-009-1732-z","article-title":"Qualitative differences between C57BL\/6J and DBA\/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration","volume":"208","author":"Elmer","year":"2010","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2021.107887_b0430","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-2259-6","article-title":"Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL\/6 and DBA\/2 inbred strains","volume":"181","author":"Orsini","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2021.107887_b0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.alcohol.2007.12.006","article-title":"Voluntary ethanol consumption in 22 inbred mouse strains","volume":"42","author":"Yoneyama","year":"2008","journal-title":"Alcohol."},{"key":"10.1016\/j.intimp.2021.107887_b0440","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00213-006-0305-7","article-title":"Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists","volume":"184","author":"Grabus","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.intimp.2021.107887_b0445","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-003-1647-z","article-title":"Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse","volume":"172","author":"Orsini","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.intimp.2021.107887_b0450","first-page":"497","article-title":"The difference in stress-induced analgesia in C57BL\/6 and DBA\/2 mice: a search for biochemical correlates","volume":"40","author":"Przew\u0142ocka","year":"1988","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0455","first-page":"37","article-title":"The difference in the tail-flick latency between C57BL\/6 and DBA\/2J mice","volume":"40","author":"Vetulani","year":"1988","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0460","first-page":"381","article-title":"The difference in the tail-flick but not hot-plate response latency between C57BL\/6 and DBA\/2J mice","volume":"40","author":"Vetulani","year":"1988","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0465","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1254\/jphs.FP0070653","article-title":"Complicated interaction between psychostimulants and morphine in the expression of phenotype of behavior in the dopaminergic system of BALB\/c mice","volume":"105","author":"Ito","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2021.107887_b0470","first-page":"71","article-title":"Effects of chlordiazepoxide-morphine combinations on spontaneous locomotor activity in three inbred strains of mice","volume":"247","author":"Sansone","year":"1980","journal-title":"Arch. IntPharmacodyn. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0475","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(99)00212-9","article-title":"Differences in drug-induced place conditioning between BALB\/c and C57Bl\/6 mice","volume":"65","author":"Belzung","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.intimp.2021.107887_b0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-2259-6","article-title":"Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL\/6 and DBA\/2inbred strains","volume":"181","author":"Orsini","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.intimp.2021.107887_b0485","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbr.2004.11.013","article-title":"Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing","volume":"160","author":"Sakoori","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.intimp.2021.107887_b0490","first-page":"431","article-title":"Neurochemical correlates of differences in responses to psychotropic drugs. I. Apomorphine and morphine effects on locomotor activity of C57\/BL and Balb\/C mice","volume":"41","author":"Marona-Lewicka","year":"1989","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.intimp.2021.107887_b0495","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1471-4159.2001.00599.x","article-title":"A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice","volume":"79","author":"Murphy","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2021.107887_b0500","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuroscience.2014.09.069","article-title":"Temporal and anatomic patterns of immediate-early gene expression in the forebrain of C57BL\/6 and DBA\/2 mice after morphine administration","volume":"284","author":"Zi\u00f3\u0141kowska","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2021.107887_b0505","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0014-2999(75)90300-3","article-title":"Genetically determined differences in the effects of morphine on mice","volume":"32","author":"Eidelberg","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107887_b0510","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00421259","article-title":"Morphine sensitivity and tolerance: a genetic investigation in the mouse","volume":"42","author":"Oliverio","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.intimp.2021.107887_b0515","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-3565(25)12304-5","article-title":"Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay","volume":"276","author":"Mogil","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0520","first-page":"291","article-title":"Strain-dependent effects of morphine injected into the periaqueductal gray area of mice","volume":"24","author":"Nunes-de-Souza","year":"1991","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.intimp.2021.107887_b0525","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(24)37974-1","article-title":"Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice","volume":"288","author":"Rady","year":"1999","journal-title":"J Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2021.107887_b0530","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.69.7.1835","article-title":"Coupling of a new, active morphine derivative to sepharose for affinity chromatography","volume":"69","author":"Simon","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.intimp.2021.107887_b0535","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4049\/jimmunol.110.3.667","article-title":"A measurement of the specificities of antibodies to morphine-6-succinyl-BSA by competitive inhibition of 14 C-morphine binding","volume":"110","author":"Wainer","year":"1973","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107887_b0540","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.2042-7158.1969.tb08312.x","article-title":"The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice","volume":"21","author":"Dewey","year":"1969","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:26:07Z","timestamp":1747308367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":108,"alternative-id":["S1567576921005233"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107887","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The morphine\/heroin vaccine decreased the heroin-induced antinociceptive and reinforcing effects in three inbred strains mouse","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107887"}}